Abstract CN07-02: Immunotoxins targeting GPC3 for liver cancer

Mitchell Ho; Bryan D Fleming; Tim F Greten; Ira Pastan

doi:10.1158/1535-7163.TARG-19-CN07-02

AACR Journals

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Journals

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Therapeutic Agents: Biological

Abstract CN07-02: Immunotoxins targeting GPC3 for liver cancer

Mitchell Ho, Bryan D Fleming, Tim F Greten and Ira Pastan

Mitchell Ho

National Cancer Institute, Bethesda, MD.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bryan D Fleming

National Cancer Institute, Bethesda, MD.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tim F Greten

National Cancer Institute, Bethesda, MD.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ira Pastan

National Cancer Institute, Bethesda, MD.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1535-7163.TARG-19-CN07-02 Published December 2019

Article
Info & Metrics

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: December 2019 to January 2021

	Abstract	Full-text HTML	PDF
Total	276	0	0

Cited By

Article Information

Volume 18, Issue 12 Supplement, pp. CN07-02

DOI

https://doi.org/10.1158/1535-7163.TARG-19-CN07-02

Published By

American Association for Cancer Research

Print ISSN

1535-7163

Online ISSN

1538-8514

Author Information

Mitchell Ho,
Bryan D Fleming,
Tim F Greten, and
Ira Pastan

National Cancer Institute, Bethesda, MD.

Molecular Cancer Therapeutics: 18 (12 Supplement)

December 2019
Volume 18, Issue 12 Supplement

Table of Contents

Search for this keyword

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Abstract CN07-02: Immunotoxins targeting GPC3 for liver cancer

Message Subject (Your Name) has forwarded a page to you from Molecular Cancer Therapeutics

Message Body (Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Abstract CN07-02: Immunotoxins targeting GPC3 for liver cancer

Mitchell Ho, Bryan D Fleming, Tim F Greten and Ira Pastan

Mol Cancer Ther December 1 2019 (18) (12 Supplement) CN07-02; DOI: 10.1158/1535-7163.TARG-19-CN07-02

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Abstract CN07-02: Immunotoxins targeting GPC3 for liver cancer

Mitchell Ho, Bryan D Fleming, Tim F Greten and Ira Pastan

Mol Cancer Ther December 1 2019 (18) (12 Supplement) CN07-02; DOI: 10.1158/1535-7163.TARG-19-CN07-02

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics

Cited By...

Therapeutic Agents: Biological

Abstract LB-C08: Imipridone ONC212 induces apoptosis, suppresses autophagy and synergizes upon GRP132 knockdown or exposure to lactic acid in preclinical studies of the pancreatic cancer microenvironment
Abstract LB-C07: Preclinical evaluation of MCLA-129: A bispecific antibody targeting c-MET and EGFR

Show more Therapeutic Agents: Biological

Therapeutic Agents: Biological: Oral Presentations - Invited Abstracts

Abstract CN01-02: Maximizing the potential of bispecific antibodies for cancer drug development
Abstract CN04-03: DNA vaccines as treatment for prostate cancer - understanding mechanisms of resistance

Show more Therapeutic Agents: Biological: Oral Presentations - Invited Abstracts

Home
Alerts
Feedback
Privacy Policy

Articles

Online First
Current Issue
Past Issues
Meeting Abstracts

Info for

Authors
Subscribers
Advertisers
Librarians

About MCT

About the Journal
Editorial Board
Permissions
Submit a Manuscript

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Main menu

User menu

Search

Abstract CN07-02: Immunotoxins targeting GPC3 for liver cancer

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: December 2019 to January 2021

Cited By

Article Information

Author Information

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Therapeutic Agents: Biological

Therapeutic Agents: Biological: Oral Presentations - Invited Abstracts

Articles

Info for

About MCT